Record NNP B-NP O
date NN I-NP O
: : O O
2077-06-19 CD O B-DATE
MANAMANA NNP B-NP B-HOSPITAL
MEDICAL NNP I-NP O
CONSULT NNP I-NP O
NOTE NNP I-NP O
PATIENT NNP B-NP O
: : O O
Vaughn NNP B-NP I-PATIENT
, , O I-PATIENT
Frank NNP B-NP I-PATIENT
R NN I-NP I-PATIENT
. . O O
MANAMANA NNP B-NP B-HOSPITAL
MR# NNP I-NP O
: : O O
6767510 CD O B-MEDICALRECORD
PCP NNP B-NP O
: : O O
Henry NNP B-NP B-DOCTOR
Jenkins NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
( -LRB- I-NP O
503 JJ I-NP B-PHONE
155-7742 CD I-NP I-PHONE
) -RRB- O O
PSYCH NNP B-NP O
: : O O
Brittany NNP B-NP B-DOCTOR
Prince NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
CONTACT NN B-NP O
: : O O
Mother NNP B-NP O
, , O O
Haley NNP B-NP B-PATIENT
Vaughn NNP I-NP I-PATIENT
( -LRB- I-NP O
158 CD I-NP B-PHONE
857-4114 CD I-NP I-PHONE
) -RRB- O O
SOURCE NNP B-NP O
: : O O
Patient NNP B-NP O
; : O O
M.D. NNP B-NP O
Passoff NNP I-NP O
; : O O
Previous JJ B-NP O
Medical NNP I-NP O
Records NNPS I-NP O
PRECAUTIONS NNS B-NP O
: : O O
MRS NNP B-NP O
A NNP I-NP O
; : O O
VRE RB O O
PRIMARY NNP B-NP O
SERVICE NNP I-NP O
: : O O
Psychiatry NNP B-NP O
Service NNP I-NP O
( -LRB- I-NP O
Internal JJ I-NP O
Medicine NN I-NP O
) -RRB- O O
CONSULT NN B-NP O
DATE NNP I-NP O
: : O O
6/19/77 CD O B-DATE
TIME NN B-NP O
: : O O
2:00 CD B-NP O
PM NNP I-NP O
CC NNP B-NP O
: : O O
Suicidal NNP B-NP O
ideation NN I-NP O
REASON NNP B-NP O
for IN B-PP O
CONSULT NNP B-NP O
: : O O
Evaluation NN B-NP O
for IN B-PP O
history NN B-NP O
of IN B-PP O
medical JJ B-NP O
problems NNS I-NP O
HPI NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
a DT B-NP O
33 CD I-NP B-AGE
y NN I-NP O
.o NN I-NP O
. . B-NP O
male NN I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
IDDM2 NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
recent JJ B-NP O
prolonged JJ I-NP O
hospitalization NN I-NP O
for IN B-PP O
Fournier&#8217 CD B-NP O
;s NNS I-NP O
gangrene NN B-ADVP O
at IN B-PP O
MANAMANA NNP B-NP B-HOSPITAL
, , O O
and CC O O
depression NN B-NP O
, , O O
who WP B-NP O
was VBD B-VP O
transferred VBN I-VP O
to TO B-PP O
the DT B-NP O
MANAMANA NNP I-NP B-HOSPITAL
Psychiatry NNP I-NP O
by IN B-PP O
his PRP$ B-NP O
MEDIQUIK NNP I-NP B-HOSPITAL
psychiatrist NN I-NP O
, , O O
Dr. NNP B-NP O
Prince NNP I-NP B-DOCTOR
from IN B-PP O
her PRP$ B-NP O
clinic NN I-NP O
today NN I-NP O
for IN B-PP O
active JJ B-NP O
suicidal NN I-NP O
ideation NN I-NP O
. . O O
Dr. NNP B-NP O
Prince NNP I-NP B-DOCTOR
had VBD B-VP O
arranged VBN I-VP O
involuntary JJ B-NP O
hospitalization NN I-NP O
for IN B-PP O
this DT B-NP O
pt NN I-NP O
with IN B-PP O
campus NN B-NP O
security NN I-NP O
and CC O O
EMS NNP B-NP O
, , O O
prior RB B-ADVP O
to TO B-PP O
his PRP$ B-NP O
arrival NN I-NP O
for IN B-PP O
the DT B-NP O
appointment NN I-NP O
. . O O
However RB B-ADVP O
, , O O
per IN B-PP O
Mr. NNP B-NP O
Vaughn NNP I-NP B-PATIENT
, , O O
he PRP B-NP O
arrived VBD B-VP O
to TO B-PP O
the DT B-NP O
appointment NN I-NP O
only RB B-ADVP O
with IN B-PP O
the DT B-NP O
expectation NN I-NP O
of IN B-PP O
discussing VBG B-VP O
his PRP$ B-NP O
depression NN I-NP O
and CC O O
refilling VBG B-VP O
his PRP$ B-NP O
Celexa NNP I-NP O
, , O O
which WDT B-NP O
he PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
unable JJ B-ADJP O
to TO B-VP O
take VB I-VP O
for IN B-PP O
the DT B-NP O
past JJ I-NP O
2 CD I-NP O
weeks NNS I-NP O
, , O O
due JJ B-PP O
to TO I-PP O
an DT B-NP O
expired VBN I-NP O
prescription NN I-NP O
. . O O
Dr. NNP B-NP O
Prince NNP I-NP B-DOCTOR
documents VBZ B-VP O
a DT B-NP O
discussion NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
tearful JJ B-ADJP O
and CC I-ADJP O
emotional JJ I-ADJP O
, , O O
while IN B-SBAR O
describing VBG B-VP O
active JJ B-NP O
suicidal NN I-NP O
ideation NN I-NP O
with IN B-PP O
a DT B-NP O
plan NN I-NP O
to TO B-VP O
overdose VB I-VP O
on IN B-PP O
oxycodone NN B-NP O
. . O O
He PRP B-NP O
reportedly RB B-ADVP O
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
this DT B-NP O
past JJ I-NP O
week NN I-NP O
, , O O
where WRB B-ADVP O
he PRP B-NP O
had VBD B-VP O
more JJR B-NP O
than IN I-NP O
a DT I-NP O
hundred CD I-NP O
oxycodone CD I-NP O
pills NNS I-NP O
in IN B-PP O
his PRP$ B-NP O
hand NN I-NP O
, , O O
but CC O O
did VBD B-VP O
not RB I-VP O
follow VB I-VP O
through IN B-PP O
on IN B-PP O
his PRP$ B-NP O
plans NNS I-NP O
. . O O
Given VBN B-VP O
concern NN B-NP O
for IN B-PP O
imminent JJ B-NP O
danger NN I-NP O
, , O O
a DT B-NP O
Section NN I-NP O
12 CD I-NP O
was VBD B-VP O
completed VBN I-VP O
, , O O
and CC O O
pt NN B-NP O
was VBD B-VP O
transferred VBN I-VP O
to TO B-PP O
the DT B-NP O
MANAMANA NNP I-NP B-HOSPITAL
ED. NNP I-NP O
The DT B-NP O
pt NN I-NP O
does VBZ B-VP O
admit VB I-VP O
to TO B-PP O
phobias NNS B-NP O
of IN B-PP O
the DT B-NP O
hospital NN I-NP O
, , O O
and CC O O
strong JJ B-NP O
desire NN I-NP O
to TO B-VP O
avoid VB I-VP O
admission NN B-NP O
. . O O
However RB B-ADVP O
, , O O
he PRP B-NP O
states VBZ B-VP O
that IN B-PP O
his PRP$ B-NP O
last JJ I-NP O
suicidal NN I-NP O
ideation NN I-NP O
was VBD B-VP O
approximately RB B-NP O
2 CD I-NP O
weeks NNS I-NP O
ago RB B-ADVP O
, , O O
and CC O O
that IN B-SBAR O
he PRP B-NP O
changed VBD B-VP O
his PRP$ B-NP O
mind NN I-NP O
, , O O
once RB B-ADVP O
he PRP B-NP O
realized VBD B-VP O
his PRP$ B-NP O
mother NN I-NP O
&#8217 CC I-NP O
;s NN I-NP O
soon-to-be JJ I-NP O
ex-husband NN I-NP O
, , O O
who WP B-NP O
has VBZ B-VP O
been VBN I-VP O
threatening VBG I-VP O
her PRP B-NP O
, , O O
will MD B-VP O
be VB I-VP O
released VBN I-VP O
from IN B-PP O
prison NN B-NP O
soon RB B-ADVP O
. . O O
Moreover RB B-ADVP O
, , O O
he PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
he PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
taking VBG I-VP O
all DT B-NP O
his PRP$ I-NP O
medications NNS I-NP O
, , O O
checking VBG B-VP O
his PRP$ B-NP O
insulin NN I-NP O
at IN B-NP O
least JJS I-NP O
four CD I-NP O
times NNS I-NP O
a DT B-NP O
day NN I-NP O
for IN B-PP O
his PRP$ B-NP O
sliding VBG I-NP O
scale NN I-NP O
, , O O
and CC O O
changing VBG B-VP O
the DT B-NP O
dressings NNS I-NP O
on IN B-PP O
his PRP$ B-NP O
sacral JJ I-NP O
and CC I-NP O
scrotal JJ I-NP O
wounds NNS I-NP O
, , O O
with IN B-PP O
intent NN B-NP O
to TO B-PP O
improving VBG B-VP O
his PRP$ B-NP O
health NN I-NP O
. . O O
The DT B-NP O
Medical NNP I-NP O
Service NNP I-NP O
was VBD B-VP O
asked VBN I-VP O
to TO B-VP O
evaluate VB I-VP O
the DT B-NP O
pt NN I-NP O
for IN B-PP O
active JJ B-NP O
and CC I-NP O
impending JJ I-NP O
medical JJ I-NP O
issues NNS I-NP O
prior RB B-ADVP O
to TO B-PP O
admission NN B-NP O
to TO B-PP O
a DT B-NP O
Psychiatry NNP I-NP O
Service NNP I-NP O
. . O O
PMH/PSH NNS B-NP O
1 LS O O
. . B-NP O
Depression NNP I-NP O
: : O O
Symptoms NNP B-NP O
since IN B-PP O
age NN B-NP O
12 CD I-NP B-AGE
. . O O
2. DT B-NP O
IDDM2 NNP I-NP O
: : O O
Diagnosed VBN B-VP O
at IN B-PP O
age NN B-NP O
18 CD I-NP B-AGE
. . O O
Was VBD B-VP O
previously RB B-ADVP O
on IN B-PP O
oral JJ B-NP O
hypoglycemics NNS I-NP O
, , O O
but CC O O
now RB B-ADVP O
on IN B-PP O
insulin NN B-NP O
. . O O
When WRB B-ADVP O
pt NN B-NP O
had VBD B-VP O
lost VBN I-VP O
weight NN B-NP O
and CC O O
down IN B-NP O
to TO I-NP O
210 CD I-NP O
lbs NNS I-NP O
, , O O
he PRP B-NP O
did VBD B-VP O
not RB I-VP O
require VB I-VP O
insulin NN B-NP O
. . O O
Last JJ B-NP O
Hgb NNP I-NP O
A1c NNP I-NP O
of IN B-PP O
11.3 CD B-NP O
in IN B-PP O
December NNP B-NP B-DATE
2076 CD I-NP I-DATE
. . O O
3. DT B-NP O
Microalbuminuria NNP I-NP O
: : O O
Microalbumin NNP B-NP O
of IN B-PP O
286mg/dl CD B-NP O
( -LRB- I-NP O
12/20/76 CD I-NP B-DATE
) -RRB- I-NP O
and CC I-NP O
Malb/Cre NNP I-NP O
ratio NN I-NP O
of IN B-PP O
4133 CD B-NP O
. . O O
Pt NNP B-NP O
was VBD B-VP O
previously RB I-VP O
taking VBG I-VP O
Lisinopril NNP B-NP O
40mg CD I-NP O
daily JJ I-NP O
and CC I-NP O
Losartan NNP I-NP O
25mg CD I-NP O
daily JJ I-NP O
, , O O
but CC O O
is VBZ B-VP O
not RB I-VP O
taking VBG I-VP O
an DT B-NP O
ACE-inhibitor NNP I-NP O
or CC I-NP O
ARB NNP I-NP O
currently RB B-ADVP O
. . O O
4 LS O O
. . B-NP O
Hyperlipidemia NNP I-NP O
: : O O
Primarily RB B-NP O
hypertriglyceridemia NN I-NP O
. . O O
TG '' O O
as RB B-ADJP O
high JJ I-ADJP O
as IN B-PP O
3060 CD B-NP O
on IN B-PP O
6/20/76 CD B-NP B-DATE
in IN B-PP O
setting NN B-NP O
of IN B-PP O
poorly RB B-NP O
controlled VBN I-NP O
DM2. DT B-NP O
Last JJ I-NP O
TG NN I-NP O
of IN B-PP O
346 CD B-NP O
on IN B-PP O
2/13/77 CD B-NP B-DATE
. . O O
Pt NNP B-NP O
was VBD B-VP O
previously RB B-ADVP O
on IN B-PP O
Fenofibrate NNP B-NP O
145mg CD I-NP O
daily JJ I-NP O
, , O O
but CC O O
is VBZ B-VP O
not RB I-VP O
taking VBG I-VP O
it PRP B-NP O
currently RB B-ADVP O
. . O O
5 CD B-NP O
. . O O
HTN NNP B-NP O
: : O O
On IN B-PP O
Toprol NNP B-NP O
XL. NNP I-NP O
6 CD B-LST O
. . O O
Fournier&#8217 CD B-NP O
;s NNP I-NP O
Gangrene NNP I-NP O
: : O O
Pt NNP B-NP O
presented VBD B-VP O
to TO B-PP O
EDUCARE-PULLMAN NNP B-NP B-HOSPITAL
Clinic NNP I-NP O
on IN B-PP O
1/21/77 CD B-NP B-DATE
with IN B-PP O
buttock NN B-NP O
pain NN I-NP O
and CC I-NP O
folliculitis NN I-NP O
that WDT B-NP O
did VBD B-VP O
not RB I-VP O
improve VB I-VP O
on IN B-PP O
oral JJ B-NP O
antibiotics NNS I-NP O
. . O O
Subsequent NNP B-NP O
scrotal JJ I-NP O
pain NN I-NP O
, , O O
swelling VBG B-VP O
, , O O
and CC O O
found VBD B-VP O
to TO I-VP O
have VB I-VP O
Fournier&#8217 CD B-NP O
;s NNS I-NP O
gangrene NN I-NP O
requiring VBG B-VP O
surgical JJ B-NP O
debridement NN I-NP O
at IN B-PP O
MANAMANA NNP B-NP B-HOSPITAL
on IN B-PP O
2/01/77 CD B-NP B-DATE
. . O O
Pt NNP B-NP O
had VBD B-VP O
prolonged VBN I-VP O
hospitalization NN B-NP O
with IN B-PP O
ICU JJ B-NP O
course NN I-NP O
, , O O
multiple JJ B-NP O
wound NN I-NP O
closures NNS I-NP O
, , O O
diverting VBG B-VP O
colostomy NN B-NP O
, , O O
and CC O O
extended VBD B-VP O
IV NNP B-NP O
antibiotic JJ I-NP O
course NN I-NP O
. . O O
Pt NNP B-NP O
was VBD B-VP O
discharged VBN I-VP O
on IN B-PP O
3/12/77 CD B-NP B-DATE
with IN B-PP O
sacral JJ B-NP O
and CC I-NP O
scrotal JJ I-NP O
wounds NNS I-NP O
improving VBG B-VP O
, , O O
but CC O O
not RB B-VP O
fully RB I-VP O
healed VBN I-VP O
. . O O
He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
followed VBN I-VP O
closely RB B-ADVP O
by IN B-PP O
MANAMANA NNP B-NP B-HOSPITAL
Surgery NNP I-NP O
with IN B-PP O
significant JJ B-NP O
improvements NNS I-NP O
. . O O
7. DT B-NP O
S/p NNP I-NP O
Diverting NNP I-NP O
Colostomy NNP I-NP O
: : O O
S/p NNP B-NP O
diverting VBG I-NP O
colostomy NN I-NP O
on IN B-PP O
2/6/77 CD B-NP B-DATE
in IN B-PP O
setting NN B-NP O
of IN B-PP O
recovery NN B-NP O
following VBG B-VP O
Fournier&#8217 CD B-NP O
;s JJ I-NP O
gangrene NN I-NP O
. . O O
On IN B-PP O
6/9/77 CD B-NP B-DATE
, , O O
pt VBD B-VP O
underwent JJ B-NP O
dilatation NN I-NP O
of IN B-PP O
the DT B-NP O
skin NN I-NP O
surrounding VBG B-VP O
the DT B-NP O
colostomy NN I-NP O
site NN I-NP O
, , O O
to TO B-VP O
relieve VB I-VP O
a DT B-NP O
large JJ I-NP O
bowel NN I-NP O
obstruction NN I-NP O
. . O O
8. CD B-NP O
Obesity NN I-NP O
: : O O
Currently RB B-ADVP O
weighs VBZ B-VP O
298 RP B-NP O
lbs NNS I-NP O
. . O O
9 CD B-NP O
. . O O
Migraine NNP B-NP O
headaches NNS I-NP O
10 CD B-NP O
. . I-NP O
S/p NNP I-NP O
Cholecystectomy NNP I-NP O
in IN B-PP O
2065 CD B-NP B-DATE
MEDICATIONS NNS B-NP O
: : O O
( -LRB- B-NP O
Confirmed VBN B-VP O
with IN B-PP O
pt NN B-NP O
) -RRB- O O
1 CD B-NP O
. . O O
Toprol NNP B-PP O
XL NNP B-NP O
100mg CD I-NP O
PO NNP I-NP O
once RB B-ADVP O
daily RB O O
2. DT B-NP O
NPH NNP I-NP O
Insulin NNP I-NP O
30units VBZ B-VP O
SC NNP B-NP O
QAM NNP I-NP O
with IN B-PP O
breakfast NN B-NP O
3. DT B-NP O
NPH NNP I-NP O
Insulin NNP I-NP O
10units VBZ B-VP O
SC NNP B-NP O
QPM NNP I-NP O
with IN B-PP O
dinner NN B-NP O
4 CD B-LST O
. . O O
Regular NNP B-NP O
Insulin NNP I-NP O
Sliding NNP I-NP O
Scale NNP I-NP O
SC NNP I-NP O
QAC NNP I-NP O
+ NNP I-NP O
QHS . O O
- : O O
For IN B-PP O
FS NNS B-NP O
of IN B-PP O
130-170 CD B-NP O
, , O O
give VBP B-VP O
2units PRP$ I-VP O
- : O O
For IN B-PP O
FS NNS B-NP O
of IN B-PP O
171-200 CD B-NP O
, , O O
give VBP B-VP O
4units NNS B-NP O
- : O O
For IN B-PP O
FS NNS B-NP O
of IN B-PP O
201-250 CD B-NP O
, , O O
give VBP B-VP O
6units NNS B-NP O
- : O O
For IN B-PP O
FS NNS B-NP O
greater JJR B-NP O
than IN I-NP O
250 CD I-NP O
, , O O
give VBP B-VP O
10units PRP$ I-VP O
5 CD B-NP O
. . O O
Celexa NNP B-NP O
60mg CD I-NP O
PO NNP I-NP O
once RB B-ADVP O
daily RB B-ADVP O
( -LRB- B-NP O
stopped VBD B-VP O
taking VBG I-VP O
2 CD B-NP O
weeks NNS I-NP O
ago RB B-ADVP O
) -RRB- O O
6 CD B-NP O
. . O O
Klonopin NNP B-NP O
1mg CC I-NP O
PO NNP I-NP O
once RB B-ADVP O
daily RB B-ADVP O
PRN NNP B-NP O
for IN B-PP O
anxiety NN B-NP O
( -LRB- I-NP O
last JJ B-NP O
dose NN I-NP O
was VBD B-VP O
3 CD B-NP O
days NNS I-NP O
ago RB B-ADVP O
) -RRB- O O
7. . B-NP O
MVI NNP I-NP O
1tablet VBD B-VP O
PO NNP B-NP O
once RB I-NP O
daily RB O O
8. DT B-NP O
Zinc NNP I-NP O
supplements NNS I-NP O
ALLERGIES NNS B-NP O
: : O O
HCTZ NNP B-NP O
-&gt NN I-NP O
; : O O
hyponatremia NN B-NP O
Social NNP B-NP O
History NNP I-NP O
: : O O
Lives NNS B-NP O
in IN B-PP O
Waupun NNP B-NP B-CITY
, , O O
AL NNP B-NP B-STATE
with IN B-PP O
his PRP$ B-NP O
mother NN I-NP O
, , O O
Haley NNP B-NP B-PATIENT
Vaughn NNP I-NP I-PATIENT
Occupation NNP B-NP O
: : O O
Former NNP B-NP O
Motor NNP I-NP B-PROFESSION
Vehicle NNP I-NP I-PROFESSION
Assembling NNP I-NP I-PROFESSION
Supervisor NNP I-NP I-PROFESSION
. . I-NP O
Currently NNP I-NP O
Publishing NNP I-NP B-PROFESSION
Manager NNP I-NP I-PROFESSION
. . O O
Tobacco NNP B-NP O
: : O O
Denies NNS B-NP O
EtOH NNP B-NP O
: : O O
Rare NNP B-VP O
. . B-NP O
1 CD I-NP O
drink NN I-NP O
a DT B-NP O
year NN I-NP O
. . O O
Illicits NNS B-NP O
: : O O
Denies NNS B-NP O
IVDU, IN B-PP O
all DT B-NP O
illicits NNS I-NP O
, , O O
including VBG B-PP O
marijuana NN B-NP O
. . O O
ROS NNP B-NP O
: : O O
Please VB B-VP O
refer VB I-VP O
to TO B-PP O
HPI NNP B-NP O
for IN B-PP O
pertinent JJ B-NP O
positives NNS I-NP O
and CC I-NP O
negatives NNS I-NP O
. . O O
General NNP B-NP O
: : O O
Denies NNS B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
general JJ B-NP O
weakness NN I-NP O
. . O O
Denies NNS B-NP O
light-headedness NN I-NP O
. . O O
Skin NNP B-NP O
: : O O
No DT B-NP O
changing VBG I-NP O
moles NNS I-NP O
, , O O
lumps NNS B-NP O
. . O O
Sacral NNP B-NP O
and CC O O
scrotal JJ B-NP O
wounds NNS I-NP O
stable JJ B-ADJP O
and CC O O
improving VBG B-UCP O
Head NN B-NP O
: : O O
Occasional JJ B-NP O
migraine JJ I-NP O
headaches NNS I-NP O
. . B-NP O
Denies NNS I-NP O
trauma . O O
Eyes NNP B-NP O
: : O O
No DT B-NP O
visual JJ I-NP O
changes NNS I-NP O
or CC O O
drainage NN B-NP O
Nose NNP B-NP O
: : O O
No DT B-NP O
epistaxis NN I-NP O
, , O O
obstruction NN B-NP O
, , O O
sinusitis NN B-NP O
Mouth NNP B-NP O
: : O O
No DT B-NP O
sores NNS I-NP O
, , O O
no DT B-NP O
sore JJ I-NP O
throat NN I-NP O
Resp NNP B-NP O
: : O O
No DT B-NP O
wheezing JJ I-NP O
, , I-NP O
hemoptysis NN I-NP O
, , I-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
CV NNP B-NP O
: : O O
No DT B-NP O
CP NNP I-NP O
, , O O
angina NN B-NP O
, , O O
DOE NNP B-NP O
, , O O
PND NNP B-NP O
, , O O
orthopnea NN B-NP O
, , O O
palpitations NNS B-NP O
GI NNP B-NP O
: : O O
Denies NNS B-NP O
ABD NNP B-NP O
pain NN I-NP O
, , O O
constipation NN B-NP O
, , O O
diarrhea NN B-NP O
. . O O
Colostomy NN B-NP O
site NN I-NP O
with IN B-PP O
good JJ B-NP O
output NN I-NP O
and CC B-PP O
without IN B-PP O
bleeding VBG B-UCP O
GU NNP B-NP O
: : O O
No DT B-NP O
dysuria NN I-NP O
, , I-NP O
nocturia NN I-NP O
, , I-NP O
hematuria NN I-NP O
, , I-NP O
frequency NN I-NP O
, , I-NP O
urgency NN I-NP O
, , I-NP O
hesitancy NN I-NP O
. . O O
Denies NNS B-NP O
urinary JJ B-NP O
incontinence NN I-NP O
Neuro NNP B-NP O
: : O O
No DT B-NP O
dizziness NN I-NP O
, , O O
involuntary JJ B-NP O
movements NNS I-NP O
, , O O
syncope NN B-NP O
, , O O
loss NN B-NP O
of IN B-PP O
coordination NN B-NP O
, , O O
paralysis NN B-NP O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
VS NNP B-NP O
: : O O
T NNP B-NP O
: : O O
97.6 CD B-NP O
P NNP I-NP O
: : O O
90 CD B-NP O
( -LRB- I-NP O
Regular JJ I-NP O
) -RRB- I-NP O
BP NNP I-NP O
: : O O
126/72 CD B-NP O
RR NN I-NP O
: : O O
18 CD B-NP O
O2 CD I-NP O
Sat NNP I-NP O
: : O O
98 CD B-NP O
% NN I-NP O
on IN B-PP O
R.A. NNP B-NP O
Wt NNP I-NP O
: : O O
298 CD B-NP O
lbs NNS I-NP O
GEN NNP B-NP O
: : O O
In IN B-PP O
NAD. NNP B-NP O
Obese NNP I-NP O
. . I-NP O
Comfortable NNP I-NP O
, , O O
lying VBG B-VP O
flat JJ B-ADJP O
in IN B-PP O
bed NN B-NP O
. . O O
HEENT NNP B-NP O
: : O O
NC/AT. NNP B-NP O
PERRL. NNP I-NP O
EOMI NNP I-NP O
. . I-NP O
OP NNP I-NP O
clear JJ I-NP O
without IN B-PP O
lesions NNS B-NP O
, , O O
MMM NNP B-NP O
without IN B-PP O
erosions NNS B-NP O
. . O O
NECK NNP B-NP O
: : O O
Soft NNP B-NP O
, , O O
supple NN B-NP O
, , O O
FROM NNP B-NP O
, , O O
no DT B-NP O
thyromegaly RB I-NP O
. . O O
2+ JJ B-NP O
carotid NN I-NP O
pulses NNS I-NP O
bilaterally RB B-ADVP O
without IN B-PP O
delay NN B-NP O
. . O O
No DT B-NP O
cervical JJ I-NP O
spine NN I-NP O
tenderness NN I-NP O
. . O O
CHEST NNP B-NP O
: : O O
Clear NNP B-NP O
to TO B-VP O
auscultation VB I-VP O
bilaterally RB B-ADVP O
. . O O
No DT B-NP O
wheezes NNPS I-NP O
or CC I-NP O
rales NNS I-NP O
. . O O
CV NNP B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
. . O O
Normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
. . O O
No DT B-NP O
m/r/g NN I-NP O
. . O O
No DT B-NP O
PA NNP I-NP O
tap NN I-NP O
or CC I-NP O
RV NN I-NP O
heave VBP B-VP O
. . B-NP O
PMI NNP I-NP O
along IN B-PP O
mid-axillary JJ B-NP O
line NN I-NP O
. . O O
JVP '' O O
of IN B-PP O
7.5 CD B-NP O
cm NN I-NP O
H2O. . O O
ABD NNP B-NP O
: : O O
+ NN B-NP O
bowel NN I-NP O
sounds NNS I-NP O
; : O O
Soft NNP B-NP O
, , O O
NT NNP B-NP O
, , O O
obese NN B-NP O
. . O O
No DT B-NP O
organomegaly NNP I-NP O
. . O O
No DT B-NP O
rebound NN I-NP O
tenderness NN I-NP O
, , O O
no DT B-NP O
peritoneal NN I-NP O
signs NNS I-NP O
, , O O
no RB B-NP O
fluid JJ I-NP O
wave NN I-NP O
. . O O
LLQ '' O O
colostomy NN B-NP O
site NN I-NP O
with IN B-PP O
good JJ B-NP O
output NN I-NP O
of IN B-PP O
brown JJ B-NP O
stool NN I-NP O
. . O O
Colostomy VBG B-VP O
bag NN B-NP O
properly RB B-VP O
secured VBN I-VP O
. . O O
BACK NNP B-NP O
: : O O
No DT B-NP O
focal JJ I-NP O
or CC I-NP O
paraspinal JJ I-NP O
tenderness NN I-NP O
. . O O
EXT NNP B-NP O
: : O O
Warm NNP B-NP O
. . O O
No DT B-NP O
L.E. NNP I-NP O
edema NN I-NP O
. . O O
No DT B-NP O
c/c NN I-NP O
. . B-NP O
2+ CD I-NP O
DP NNP I-NP O
and CC I-NP O
PTs NNP I-NP O
bilaterally RB B-ADVP O
. . O O
DERM NNP B-NP O
: : O O
0.5cm VB B-VP O
open JJ B-NP O
wound NN I-NP O
in IN B-PP O
sacram NN B-NP O
with IN B-PP O
surrounding VBG B-NP O
erythema NN I-NP O
. . B-VP O
1cm RBR B-NP O
open JJ I-NP O
wound NN I-NP O
at IN B-PP O
base NN B-NP O
of IN B-PP O
scrotum NN B-NP O
, , O O
close RB B-ADVP O
to TO B-PP O
perineum NN B-NP O
. . O O
Dressing '' O O
in IN B-PP O
place NN B-NP O
. . O O
No DT B-NP O
pus FW I-NP O
or CC I-NP O
drainage NN I-NP O
expressed VBN B-VP O
from IN B-PP O
both DT B-NP O
wounds NNS I-NP O
. . O O
When WRB B-VP O
compared VBN I-VP O
to TO B-PP O
descriptions NNS B-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
, , O O
and CC O O
per IN B-PP O
pt NN B-NP O
, , O O
both DT B-NP O
wounds NNS I-NP O
are VBP B-VP O
continuing VBG I-VP O
to TO I-VP O
improve VB I-VP O
. . O O
NEURO NNP B-NP O
: : O O
Alert NNP B-NP O
and CC O O
oriented VBN B-VP O
x NN B-NP O
3. . O O
PSYCH NNP B-NP O
: : O O
Denies NNS B-NP O
SI NNP I-NP O
and CC I-NP O
HI. NNP I-NP O
Rest NNP I-NP O
of IN B-PP O
exam NN B-NP O
deferred VBN B-VP O
to TO B-PP O
Internal NNP B-NP O
Medicine NNP I-NP O
Evaluation NNP I-NP O
. . O O
EKG NNP B-NP O
: : O O
Normal JJ B-ADJP O
sinus IN B-PP O
rhythm NN B-NP O
at IN B-PP O
95 CD B-NP O
bpm NN I-NP O
. . O O
Normal JJ B-NP O
axis NNS I-NP O
. . O O
Poor NNP B-NP O
R NN I-NP O
wave NN I-NP O
progression NN I-NP O
. . O O
Non-specific JJ B-NP O
ST-T JJ I-NP O
changes NNS I-NP O
. . O O
No DT B-NP O
significant JJ I-NP O
change NN I-NP O
from IN B-PP O
previous JJ B-NP O
EKG NNP I-NP O
on IN B-PP O
6/9/77 CD B-NP B-DATE
. . O O
Labs NNS B-NP O
: : O O
HEMATOLOGY NN B-NP O
WBC NNP B-NP O
7.8 CD I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
38.0 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
41.0-53.0) CD I-NP O
% NN I-NP O
HGB NNP B-NP O
13.1 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
13.5-17.5 CD I-NP O
) -RRB- I-NP O
gm/dl . O O
RBC NNP B-NP O
4.63 CD I-NP O
( -LRB- I-NP O
4.50-5.90 CD I-NP O
) -RRB- I-NP O
mil/cmm . O O
PLT NNP B-NP O
219 CD I-NP O
( -LRB- I-NP O
150-350 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
82 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
28.4 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
34.6 CD I-NP O
( -LRB- O O
31.0-37.0) CD B-NP O
g/dl NN I-NP O
RDW NNP B-NP O
16.1 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Poly NNP B-NP O
70 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
40-70 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Lymphs NNP B-NP O
21 CD I-NP O
L NNP B-NP O
( -LRB- I-NP O
22-44 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Monos NNP B-NP O
6 CD I-NP O
( -LRB- I-NP O
4-11 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
EOS NNS B-NP O
3 CD B-NP O
(0-8 CD I-NP O
) -RRB- I-NP O
% NN I-NP O
Basos NNS B-NP O
0 CD B-NP O
(0-3 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
5.44 CD I-NP O
( -LRB- I-NP O
1.8-7.7 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Lymphs NNP I-NP O
1.64 CD I-NP O
( -LRB- I-NP O
1.0-4.8 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.49 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
0.2-0.4 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
EOS NNP I-NP O
0.19 CD I-NP O
( -LRB- I-NP O
0.1-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Basos NNP I-NP O
0.03 CD I-NP O
( -LRB- I-NP O
0.0-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Aniso NNP B-NP O
1+ CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
None NN I-NP O
) -RRB- O O
Hypo NNP B-NP O
None NN I-NP O
( -LRB- I-NP O
None NN I-NP O
) -RRB- O O
Macrocytes NNP B-NP O
None NN I-NP O
( -LRB- I-NP O
None NN I-NP O
) -RRB- O O
Microcytes NNS B-NP O
None NN B-VP O
( -LRB- B-NP O
None NN I-NP O
) -RRB- O O
CHEMISTRY NN B-NP O
Sodium NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
139 CD I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Potassium NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- B-PP O
3.9 CD B-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Chloride NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- O O
103 CD B-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
CO2 NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
26.7 CD I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
BUN NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
21 CD I-NP O
(8-25 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Creatinine NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- B-VP O
0.9 CD B-NP O
( -LRB- I-NP O
0.6-1.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Glucose FW B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
118 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
70-110 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Calcium NNP B-NP O
9.6 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Phosphorus NNP B-NP O
3.8 CD I-NP O
( -LRB- I-NP O
2.6-4.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Magnesium NNP B-NP O
1.3 CD I-NP O
L NNP I-NP O
( -LRB- B-PP O
1.4-2.0) CD B-NP O
meq/L NN I-NP O
Total JJ B-NP O
Protein NNP I-NP O
7.5 CD I-NP O
( -LRB- O O
6.0-8.3 CD B-NP O
) -RRB- I-NP O
g/dl . O O
Albumin NNP B-NP O
3.9 CD I-NP O
( -LRB- O O
3.3-5.0) CD B-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
3.6 CD I-NP O
( -LRB- I-NP O
2.6-4.1 CD I-NP O
) -RRB- I-NP O
g/dl . O O
Direct JJ B-NP O
Bilirubin NNP I-NP O
0.2 CD I-NP O
(0-0.4 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.2 CD I-NP O
( -LRB- O O
0.0-1.0) CD B-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
84 CD I-NP O
( -LRB- I-NP O
45-115 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGPT JJ B-NP O
30 CD I-NP O
( -LRB- I-NP O
10-55 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGOT JJ B-NP O
18 CD I-NP O
( -LRB- I-NP O
10-40 CD I-NP O
) -RRB- I-NP O
U/L . O O
TOXICOLOGY NNP B-NP O
SCREEN NNP I-NP O
: : O O
SERUM NNP B-NP O
TOXICOLOGY NN I-NP O
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Clonazepam NNP B-NP O
42 CD I-NP O
mcg/L NN I-NP O
REF. NNP B-NP O
RANGE NNP I-NP O
: : O O
10-70 CD O O
TOXIC NN B-NP O
: : O O
&gt NN B-NP O
;80 CD I-NP O
Ibuprofen NNP B-NP O
&lt VBD B-VP O
;17.0 CD B-NP O
mg/L NN I-NP O
REF. NNP B-NP O
RANGE NNP I-NP O
: : O O
20-70 CD O O
TOXIC NN B-NP O
: : O O
&gt NN B-NP O
;100 CD I-NP O
Tox NNP B-NP O
Panel NNP I-NP O
1 CD I-NP O
( -LRB- I-NP O
ALC NNP I-NP O
) -RRB- O O
COMPLETED VBN B-VP O
: : O O
PANEL NNP B-NP O
NEGATIVE CD I-NP O
( -LRB- B-NP O
NOTE)Drugs NNS I-NP O
included VBN B-VP O
in IN B-PP O
PANEL NNP B-NP O
1 CD I-NP O
( -LRB- I-NP O
Detection NNP I-NP O
limit NN I-NP O
in IN B-PP O
mg/L NN B-NP O
) -RRB- I-NP O
: : O O
Ethanol NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Isopropanol NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Methanol NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Tox NNP B-NP O
Panel NNP I-NP O
2 CD I-NP O
( -LRB- I-NP O
ATS NNS I-NP O
) -RRB- O O
COMPLETED VBN B-VP O
: : O O
PANEL NNP B-NP O
NEGATIVE CD I-NP O
( -LRB- B-NP O
NOTE)Drugs NNS I-NP O
included VBN B-VP O
in IN B-PP O
PANEL NNP B-NP O
2 CD I-NP O
( -LRB- I-NP O
Detection NN I-NP O
limit NN I-NP O
in IN B-PP O
mg/L NN B-NP O
) -RRB- I-NP O
: : O O
Acetaminophen NNP B-NP O
( -LRB- I-NP O
25 CD I-NP O
) -RRB- I-NP O
. . O O
Lamotrigine NNP O O
( -LRB- O O
4 CD B-NP O
) -RRB- I-NP O
. . O O
Salicylate NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Tox NNP B-NP O
Panel NNP I-NP O
3 CD I-NP O
( -LRB- I-NP O
BBT NN I-NP O
) -RRB- O O
COMPLETED VBN B-VP O
: : O O
POSITIVE CD B-NP O
FINDINGS NNS I-NP O
LISTED VBN B-VP O
ABOVE. . O O
( -LRB- B-NP O
NOTE)Drugs NNS I-NP O
included VBN B-VP O
in IN B-PP O
PANEL NNP B-NP O
3 CD I-NP O
( -LRB- I-NP O
Detection NNP I-NP O
limit NN I-NP O
in IN B-PP O
mg/L NN B-NP O
) -RRB- I-NP O
: : O O
Butalbital NNP B-NP O
( -LRB- I-NP O
10 CD I-NP O
) -RRB- I-NP O
. . O O
Carbamazepine NNP B-NP O
( -LRB- I-NP O
2 CD I-NP O
) -RRB- I-NP O
. . O O
Ibuprofen NNP O O
( -LRB- O O
17 CD B-NP O
) -RRB- I-NP O
. . O O
Pentobarbital NNP O O
( -LRB- O O
6 CD B-NP O
) -RRB- I-NP O
. . O O
Phenobarbital NNP B-NP O
( -LRB- I-NP O
11 CD I-NP O
) -RRB- I-NP O
. . O O
Phenytoin NNP O O
( -LRB- O O
5 CD B-NP O
) -RRB- I-NP O
. . O O
Secobarbital NNP O O
( -LRB- O O
5 CD B-NP O
) -RRB- I-NP O
. . O O
Tox NNP B-NP O
Panel NNP I-NP O
4 CD I-NP O
( -LRB- I-NP O
BZ NN I-NP O
) -RRB- O O
COMPLETED VBN B-VP O
: : O O
POSITIVE CD B-NP O
FINDINGS NNS I-NP O
LISTED VBN B-VP O
ABOVE. . O O
( -LRB- B-NP O
NOTE)Drugs NNS I-NP O
included VBN B-VP O
in IN B-PP O
PANEL NNP B-NP O
4 CD I-NP O
( -LRB- I-NP O
Detection NNP I-NP O
limit NN I-NP O
in IN B-PP O
mcg/L NN B-NP O
) -RRB- I-NP O
: : O O
4-OH JJ B-NP O
Glutethimide NNP I-NP O
( -LRB- I-NP O
1000 CD I-NP O
) -RRB- I-NP O
. . O O
Alprazolam NNP O O
( -LRB- O O
50 CD B-NP O
) -RRB- I-NP O
. . O O
Chlordiazepoxide NNP B-NP O
( -LRB- I-NP O
200 CD I-NP O
) -RRB- I-NP O
. . O O
Clonazepam NNP B-NP O
( -LRB- I-NP O
10 CD I-NP O
) -RRB- I-NP O
. . O O
Demoxepam NNP O O
( -LRB- O O
200 CD B-NP O
) -RRB- I-NP O
. . O O
Desalkylflurazepam NNP O O
( -LRB- O O
300 CD B-NP O
) -RRB- I-NP O
. . O O
Diazepam NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . I-NP O
Flurazepam NNP I-NP O
( -LRB- O O
500 CD B-NP O
) -RRB- I-NP O
. . O O
Glutethimide NNP O O
( -LRB- O O
1000 CD B-NP O
) -RRB- I-NP O
. . O O
Lidocaine NNP B-NP O
( -LRB- I-NP O
150 CD I-NP O
) -RRB- I-NP O
. . O O
Lorazepam NNP O O
( -LRB- O O
150 CD B-NP O
) -RRB- I-NP O
. . O O
Methaqualone NNP O O
( -LRB- O O
1000 CD B-NP O
) -RRB- I-NP O
. . O O
Norchlordiazepoxide NNP B-NP O
( -LRB- I-NP O
200 CD I-NP O
) -RRB- I-NP O
. . O O
Nordiazepam NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Oxazepam NNP O O
( -LRB- O O
150 CD B-NP O
) -RRB- I-NP O
. . O O
Quinidine NNP B-NP O
( -LRB- I-NP O
1000 CD I-NP O
) -RRB- I-NP O
. . O O
Temazepam NNP O O
( -LRB- O O
250 CD B-NP O
) -RRB- I-NP O
. . O O
Trazodone NNP O O
( -LRB- O O
250 CD B-NP O
) -RRB- I-NP O
. . O O
Tox NNP B-NP O
Panel NNP I-NP O
5 CD I-NP O
(TC NNP I-NP O
) -RRB- O O
COMPLETED VBN B-VP O
: : O O
PANEL NNP B-NP O
NEGATIVE CD I-NP O
( -LRB- B-NP O
NOTE)Drugs NNS I-NP O
included VBN B-VP O
in IN B-PP O
PANEL NNP B-NP O
5 CD I-NP O
( -LRB- I-NP O
Detection NNP I-NP O
limit NN I-NP O
in IN B-PP O
mcg/L NN B-NP O
) -RRB- I-NP O
: : O O
Amitriptyline NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Chlorpheniramine NNP O O
( -LRB- O O
40 CD B-NP O
) -RRB- I-NP O
. . O O
Chlorpromazine NN B-NP O
( -LRB- I-NP O
30 CD I-NP O
) -RRB- I-NP O
. . O O
Clomipramine NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Clozapine NNP O O
( -LRB- O O
250 CD B-NP O
) -RRB- I-NP O
. . O O
Cocaethylene NNP B-NP O
( -LRB- I-NP O
10 CD I-NP O
) -RRB- I-NP O
. . O O
Cocaine NNP O O
( -LRB- O O
10 CD B-NP O
) -RRB- I-NP O
. . O O
Cyclobenzaprine NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Pseudoephedrine NN B-NP O
( -LRB- I-NP O
500 CD I-NP O
) -RRB- I-NP O
. . O O
Desipramine NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Desmethylsertraline NNP B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
Dextromethorphan FW B-NP O
( -LRB- I-NP O
1000 CD I-NP O
) -RRB- I-NP O
. . O O
Diphenhydramine NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Disopyramide NNP O O
( -LRB- O O
150 CD B-NP O
) -RRB- I-NP O
. . O O
Doxepin NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Doxylamine NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Fluoxetine NNP O O
( -LRB- O O
50 CD B-NP O
) -RRB- I-NP O
. . O O
Fluvoxamine NNP O O
( -LRB- O O
40 CD B-NP O
) -RRB- I-NP O
. . O O
Imipramine NN B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
M-cPP NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . I-NP O
Maprotilene NNP I-NP O
( -LRB- O O
400 CD B-NP O
) -RRB- I-NP O
. . O O
Meperidine NNP O O
( -LRB- O O
200 CD B-NP O
) -RRB- I-NP O
. . O O
Mesoridazine NNP B-NP O
( -LRB- I-NP O
500 CD I-NP O
) -RRB- I-NP O
. . O O
Methadone NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Norclomipramine NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Nordoxepin NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Norfluoxetine NNP B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
Normaprotilene NNP O O
( -LRB- O O
450 CD B-NP O
) -RRB- I-NP O
. . O O
Normeperidine NNP B-NP O
( -LRB- I-NP O
200 CD I-NP O
) -RRB- I-NP O
. . O O
Norpropoxyphene NNP B-NP O
( -LRB- I-NP O
200 CD I-NP O
) -RRB- I-NP O
. . O O
Nortriptyline NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Norverapamil NNP B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
Oxycodone NNP B-NP O
( -LRB- I-NP O
40 CD I-NP O
) -RRB- I-NP O
. . O O
Paroxetine NNP O O
( -LRB- O O
50 CD B-NP O
) -RRB- I-NP O
. . O O
Pentazocine NNP O O
( -LRB- O O
1000 CD B-NP O
) -RRB- I-NP O
. . O O
Promazine NNP B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
Propoxyphene NNP B-NP O
( -LRB- I-NP O
200 CD I-NP O
).Propranolol NN I-NP O
( -LRB- B-PP O
50 CD B-NP O
) -RRB- I-NP O
. . O O
Pyrilamine NNP B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
Sertraline NN B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
Thioridazine NNP B-NP O
( -LRB- B-VP O
100 CD B-NP O
) -RRB- I-NP O
. . O O
Trifluoperazine NNP B-NP O
(60 CD I-NP O
) -RRB- I-NP O
. . O O
Trimipramine NN B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
Venlafaxine NNP O O
( -LRB- O O
50 CD B-NP O
) -RRB- I-NP O
. . O O
Verapamil NNP B-NP O
( -LRB- I-NP O
50 CD I-NP O
) -RRB- I-NP O
. . O O
URINE NNP B-NP O
TOXICOLOGY NN I-NP O
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Ur NNP B-NP O
Amphetamines NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Methamphetamines NNPS I-NP O
NEGATIVE VBP B-VP O
( -LRB- B-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Barbiturates NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Benzodiazepines NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Cocaine NNP I-NP O
Metab NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Opiates VBZ B-VP O
NEGATIVE JJ B-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Phencyclidine NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Cannabinoids NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Tricyclics NNPS I-NP O
NEGATIVE VBP B-VP O
( -LRB- B-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Methadone NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Ur NNP B-NP O
Acetaminophen NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
URINALYSIS . O O
UA-Color NN B-NP O
Yellow NNP I-NP O
( -LRB- O O
YELLOW) NN O O
UA-Turbidity NN B-NP O
Clear NNP I-NP O
( -LRB- I-NP O
CLEAR NN I-NP O
) -RRB- O O
UA-Specific JJ B-NP O
Gravity NNP I-NP O
&gt NN I-NP O
;1.030 FW I-NP O
( -LRB- B-VP O
1.001-1.035 CD B-NP O
) -RRB- O O
UA-pH NNP B-NP O
6.0 CD I-NP O
( -LRB- I-NP O
5.0-9.0) CD O O
UA-WBC NNP B-NP O
Screen NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Nitrite JJ B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Albumin NN B-NP O
3+ NN I-NP O
( -LRB- I-NP O
NEG NNP I-NP O
) -RRB- O O
UA-Glucose JJ B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Ketones NNP B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Urobilinogen NN B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Bili NNP B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Occult JJ B-NP O
Blood NN I-NP O
1+ IN B-PP O
( -LRB- B-NP O
NEG NN I-NP O
) -RRB- O O
UA-SED-RBC NNP B-NP O
3-5 CD I-NP O
(0-2 NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
UA-SED-WBC NNP B-NP O
0-2 JJ I-NP O
(0-2 NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
UA-SED-Bacteria NNP B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
Hyaline NNP B-NP O
Cast NNP I-NP O
PEND NN I-NP O
(0-5 . O O
) -RRB- B-NP O
/lpf NN I-NP O
Squamous NNP B-NP O
Cells NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
ASSESSMENT NNP B-NP O
33 CD B-NP B-AGE
y NN I-NP O
.o NN I-NP O
. . B-NP O
male NN I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
IDDM2 NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
recent JJ B-NP O
prolonged JJ I-NP O
hospitalization NN I-NP O
for IN B-PP O
Fournier&#8217 CD B-NP O
;s NNS I-NP O
gangrene NN B-ADVP O
at IN B-PP O
MANAMANA NNP B-NP B-HOSPITAL
, , O O
and CC O O
depression NN B-NP O
, , O O
who WP B-NP O
was VBD B-VP O
transferred VBN I-VP O
to TO B-PP O
the DT B-NP O
MANAMANA NNP I-NP B-HOSPITAL
Psychiatry NNP I-NP O
by IN B-PP O
his PRP$ B-NP O
MEDIQUIK NNP I-NP B-HOSPITAL
psychiatrist NN I-NP O
, , O O
Dr. NNP B-NP O
Prince NNP I-NP B-DOCTOR
from IN B-PP O
her PRP$ B-NP O
clinic NN I-NP O
today NN I-NP O
for IN B-PP O
active JJ B-NP O
suicidal NN I-NP O
ideation NN I-NP O
, , O O
who WP B-NP O
now RB B-ADVP O
denies VBZ B-VP O
suicidal JJ B-NP O
ideation NN I-NP O
, , O O
but CC O O
being VBG B-VP O
evaluated VBN I-VP O
by IN B-PP O
the DT B-NP O
medical JJ I-NP O
service NN I-NP O
for IN B-PP O
active JJ B-NP O
medical JJ I-NP O
issues NNS I-NP O
. . O O
Pt NN B-NP O
does VBZ B-VP O
have VB I-VP O
hypertension NN B-NP O
, , O O
IDDM2 NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
and CC O O
open JJ B-NP O
wounds NNS I-NP O
near IN B-PP O
his PRP$ B-NP O
scrotum NN I-NP O
and CC I-NP O
sacrum NN I-NP O
. . O O
All DT B-NP O
of IN B-PP O
these DT B-NP O
medical JJ I-NP O
issues NNS I-NP O
appear VBP B-VP O
to TO I-VP O
be VB I-VP O
stable JJ B-ADJP O
, , O O
although IN B-SBAR O
their PRP$ B-NP O
management NN I-NP O
could MD B-VP O
be VB I-VP O
fine-tuned JJ B-ADJP O
via IN B-PP O
an DT B-NP O
outpatient JJ I-NP O
basis NN I-NP O
. . O O
Hypertension NNP B-NP O
is VBZ B-VP O
being VBG I-VP O
managed VBN I-VP O
appropriately RB B-ADVP O
with IN B-PP O
a DT B-NP O
betablocker NN I-NP O
( -LRB- I-NP O
HCTZ NNP I-NP O
caused VBD B-VP O
hyponatremia NN B-NP O
) -RRB- I-NP O
, , O O
but CC O O
given VBN B-VP O
his PRP$ B-NP O
history NN I-NP O
of IN B-PP O
microalbuminuria NN B-NP O
, , O O
he PRP B-NP O
should MD B-VP O
also RB I-VP O
be VB I-VP O
on IN B-PP O
an DT B-NP O
ACE-I NNP I-NP O
or CC I-NP O
ARB. NNP I-NP O
His PRP$ B-NP O
history NN I-NP O
of IN B-PP O
hypertriglyceridemia NN B-NP O
was VBD B-VP O
persistent JJ B-ADJP O
, , O O
even RB B-PP O
in IN I-PP O
the DT B-NP O
setting NN I-NP O
of IN B-PP O
insulin NN B-NP O
for IN B-PP O
DM2 NNP B-NP O
and CC O O
improved VBD B-VP O
glycemic JJ B-NP O
control NN I-NP O
. . O O
He PRP B-NP O
would MD B-VP O
also RB I-VP O
benefit VB I-VP O
from IN B-PP O
restarting VBG B-VP O
a DT B-NP O
fibrate JJ I-NP O
, , I-NP O
such JJ B-PP O
as IN I-PP O
Lopid NNP B-NP O
. . O O
His PRP$ B-NP O
DM2 NN I-NP O
is VBZ B-VP O
quite RB B-ADJP O
stable JJ I-ADJP O
, , O O
as IN B-PP O
pt JJ B-NP O
reports NNS I-NP O
FS NNS I-NP O
of IN B-PP O
100 CD B-NP O
to TO B-PP O
200 CD B-NP O
at IN B-PP O
home NN B-NP O
with IN B-PP O
his PRP$ B-NP O
current JJ I-NP O
insulin NN I-NP O
regimen VBN B-VP O
. . O O
The DT B-NP O
wounds NNS I-NP O
should MD B-VP O
be VB I-VP O
evaluated VBN I-VP O
by IN B-PP O
his PRP$ B-NP O
Surgical JJ I-NP O
Team NN I-NP O
through IN B-PP O
his PRP$ B-NP O
outpatient NN I-NP O
appointments NNS I-NP O
. . O O
His PRP$ B-NP O
last JJ I-NP O
evaluation NN I-NP O
by IN B-PP O
General NNP B-NP O
Surgery NNP I-NP O
just RB I-NP O
2 CD I-NP O
days NNS I-NP O
ago IN O O
showed VBD B-VP O
significant JJ B-NP O
improvement NN I-NP O
, , O O
with IN B-PP O
recommendations NNS B-NP O
of IN B-PP O
BID NNP B-NP O
dressing VBG I-NP O
changes NNS I-NP O
as IN B-PP O
the DT B-NP O
pt NN I-NP O
is VBZ B-VP O
currently RB I-VP O
doing VBG I-VP O
. . O O
RECOMMENDATIONS NNS B-NP O
: : O O
1 CD B-NP O
. . O O
Continue NNP B-NP O
Toprol NNP I-NP O
XL NNP I-NP O
100mg CD I-NP O
PO NNP I-NP O
once RB B-ADVP O
daily RB O O
2. DT B-NP O
Continue NNP I-NP O
NPH NNP I-NP O
Insulin NNP I-NP O
30 CD I-NP O
units NNS I-NP O
with IN B-PP O
breakfast NN B-NP O
and CC I-NP O
10 CD I-NP O
units NNS I-NP O
with IN B-PP O
dinner NN B-NP O
. . O O
If IN B-SBAR O
pt NN B-NP O
is VBZ B-VP O
NPO NNP B-NP O
, , O O
or CC O O
refusing VBG B-VP O
to TO I-VP O
eat VB I-VP O
a DT B-NP O
meal NN I-NP O
, , O O
please VB B-VP O
give VB I-VP O
only RB B-NP O
one-half JJ I-NP O
the DT I-NP O
dose NN I-NP O
3. PRP B-NP O
Continue VB B-VP O
his PRP$ B-NP O
regular JJ I-NP O
insulin NN I-NP O
sliding VBG I-NP O
scale NN I-NP O
as IN B-PP O
outline NN B-NP O
in IN B-PP O
the DT B-NP O
Medication NNP I-NP O
List NNP I-NP O
with IN B-PP O
QAC NNP B-NP O
and CC I-NP O
QHS NNP I-NP O
fingerstick NN I-NP O
checks NNS I-NP O
4 CD B-NP O
. . O O
No DT B-NP O
concentrated JJ I-NP O
sweets NNS I-NP O
diet NN I-NP O
5 CD B-NP O
. . O O
Start NNP O O
Lisinopril NNP O O
10mg IN B-PP O
PO NNP B-NP O
once RB B-ADVP O
daily RB O O
6 CD B-NP O
. . O O
Start NNP B-NP O
Lopid NNP I-NP O
600mg JJ I-NP O
PO NN I-NP O
BID NNP I-NP O
( -LRB- O O
30 CD B-NP O
minutes NNS I-NP O
before IN B-PP O
breakfast NN B-NP O
and CC I-NP O
dinner NN I-NP O
) -RRB- O O
7. . O O
Consider VB B-VP O
checking VBG I-VP O
hemoglobin RB B-NP O
A1c JJ I-NP O
and CC I-NP O
fasting JJ I-NP O
lipid JJ I-NP O
profile NN I-NP O
with IN B-PP O
reflex JJ B-NP O
check NN I-NP O
of IN B-PP O
LDL NNP B-NP O
for IN B-PP O
triglyceridemia NN B-NP O
8. . B-NP O
Dry NNP I-NP O
sterile VBP B-VP O
dressing VBG I-VP O
changes NNS B-NP O
to TO B-PP O
his PRP$ B-NP O
scrotal NN I-NP O
and CC I-NP O
sacral JJ I-NP O
wounds NNS I-NP O
TID NNP I-NP O
and CC I-NP O
PRN NNP I-NP O
if IN B-PP O
dressing NN B-NP O
is VBZ B-VP O
soaked VBN I-VP O
9 CD B-LST O
. . O O
Will MD B-VP O
defer VB I-VP O
antidepressive JJ B-NP O
medication NN I-NP O
regimen NNS I-NP O
to TO B-PP O
Psychiatry NNP B-NP O
Service NNP I-NP O
Case NNP B-NP O
and CC I-NP O
plan NN I-NP O
discussed VBN B-VP O
in IN B-PP O
detail NN B-NP O
with IN B-PP O
Medical NNP B-NP O
Consult NNP I-NP O
Attending NNP I-NP O
, , O O
Dr. NNP B-NP O
Hector NNP I-NP B-DOCTOR
Bennett NNP I-NP I-DOCTOR
. . O O
Ulysses NNP B-NP B-DOCTOR
Jurado NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
Pager NNP I-NP O
# # I-NP O
34621 CD O B-PHONE
MANAMANA NNP B-NP B-HOSPITAL
Medical NNP I-NP O
SAR NNP I-NP O
